IU Health

Misty D. Shields, MD, PhD

IU Health

Medicine Oncology - Adult

4.9 out of 5 stars (56 ratings)
Accepting New Patients
Call to Schedule

Already a Patient? Connect on My IU Health

  • Biography
  • Insurance
  • Locations
  • Specialties & Details
  • Ratings & Reviews
  • Clinical Trials
  • Related Stories
Biography

Dr. Misty D. Shields, MD, PhD is a translational medical oncologist who specializes in the treatment of thoracic malignancies, including small cell lung cancer, non-small cell lung cancer, and neuroendocrine tumors of the lung. She has a research laboratory that focuses on understanding chemoresistance and novel treatments for small cell lung cancer

Insurance

Insurance plans accepted by this provider are below.

  • Aetna Medicare Advantage
American Health Plan of Indiana/Majestic Care Management I-SNP
  • Anthem Blue Cross Blue Shield
  • Anthem Healthy Indiana Plan
  • Anthem Hoosier Care Connect
  • Anthem Hoosier Healthwise
  • Anthem Indiana PathWays for Aging
  • Anthem Medicare Advantage HMO
  • Anthem Medicare Advantage PPO
  • Anthem Pathway Essentials Network
  • CareSource Healthy Indiana Plan
  • CareSource Hoosier Healthwise
  • Cigna HealthCare HMO
  • Cigna HealthCare PPO
  • Cigna Marketplace
Community Health Alliance
  • Community Health Network Employee Plan
Coventry/First Health
Deaconess OneCare
  • Encore Combined
  • Encore Elite
  • Encore Workers Compensation
  • Health Alliance Medicare Advantage
  • Humana Healthy Horizons Indiana PathWays for Aging
  • Humana Medicare Advantage HMO
  • Humana Medicare Advantage PFFS
  • Humana Medicare Advantage PPO
  • Indiana University Workers Compensation
  • Indiana University Health Workers Compensation
Lutheran Preferred/Three Rivers Preferred
Majestic Care Management I-SNP
  • Managed Health Services Healthy Indiana Plan
  • Managed Health Services Hoosier Care Connect
  • Managed Health Services Hoosier Healthwise
  • Managed Health Services Marketplace
  • Managed Health Services Medicare Advantage (Allwell)
MultiPlan/PHCS
NaphCare
Parkview Signature Care PPO (Excludes Allen County)
Physicians Health Plan of Northern Indiana (PHP) (Allen County)
  • Point Comfort Unaccompanied Children Program
Provider Partners Health Plan (PPHP) I-SNP
Sagamore Health Network
Select Health
SIHO
Suburban Health Organization (SHO)
  • United HealthCare Community Plan Indiana PathWays for Aging
  • United HealthCare Hoosier Care Connect
  • United HealthCare Marketplace
  • United HealthCare Medicare Advantage D-SNP
  • United HealthCare Medicare Advantage HMO
  • United HealthCare Medicare Advantage PPO
VA Community Care Network
  • Zing Health Medicare Advantage C-SNP
  • Zing Health Medicare Advantage D-SNP
  • Zing Health Medicare Advantage HMO
  • Zing Health Medicare Advantage POS
  • Zing Health Medicare Advantage PPO

Note: Although this listing was accurate at the time of posting, insurances change regularly, and insurance plans listed may not be accepted at all office locations for this provider. Please confirm with your insurance company that this provider is covered by your plan before your appointment.

Locations
Specialties & Details

Specialties:

Medicine Oncology - Adult

Conditions & Treatments:

Thoracic Oncology, Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Lung

Education

Doctorate:

University of Texas Southwestern Medical Center, Dallas, TX

School of Medicine:

University of Texas Health Houston McGovern Medical School, Houston, TX

Residency:

Vanderbilt University Medical Center, Nashville, TN

Fellowship:

University of South Florida, Moffitt Cancer Center, Tampa, FL

Fellowship:

University of Texas Southwestern Medical Center, Dallas, TX

Hospitals & Affiliations

Hospital Privileges:

IU Health North, IU Health West, IU Health Methodist/IU Health University

Physician Group:

IU Health Medical Group

Research

Research Publications
* Information provided by PubMed
Ratings & Reviews
Clinical Trials

Explore the ongoing clinical trials this provider is involved in and learn about the eligibility requirements for each one. Search the clinical trial directory to find additional clinical trials.

An Open-Label, Randomized Study of Bms-986489 (Atigotatug + Nivolumab Fixed-Dose Combination) Vs Durvalumab as Consolidation Therapy Following Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (Tigos-Ls)

View Details
Related Stories
Read More